Chinese Hepatolgy ›› 2026, Vol. 31 ›› Issue (9): 1232-1235.

• Liver Fibrosis and Cirrhosis • Previous Articles     Next Articles

The clinical application value of combined measurement of liver and spleen stiffness in non-invasive assessment of fibrosis stages in chronic hepatitis B

Wang Yiru, Ding Lei, Meng Fankun   

  1. Ultrasound Diagnosis Center,Beijing You'an Hospital,Capital Medical University,Beijing 100069,China
  • Received:2025-11-04 Online:2026-09-30 Published:2026-11-16
  • Contact: Meng Fankun, Email: mengfankun818@126.com

Abstract: Objective To explore the clinical application value of combined measurement of liver and spleen stiffness in the non-invasive assessment of liver fibrosis stages in chronic hepatitis B (CHB) patients. Methods A total of 123 CHB patients who underwent liver biopsy were enrolled in Beijing You'an Hospital, Capital Medical University. The spleen stiffness (SSM) and liver stiffness (LSM) of all patients were measured. With pathological results as the gold standard, the diagnostic value of combined liver and spleen stiffness for hepatitis B-related liver fibrosis staging was analyzed. Results Among 123 patients with hepatitis B, the number of patients at stages S0 to S4 was 18, 58, 16, 16, and 15 respectively. The LSM values were 4.30 (3.52, 6.00), 4.65 (3.80, 5.92), 7.50 (5.02, 7.97), 10.85 (9.07, 13.15), and 13.20 (11.50, 17.80) kPa, and the SSM values were 14.55 (13.42, 16.17), 14.30 (12.10, 18.22), 21.15 (16.82, 23.95), 22.85 (18.82, 27.05), and 30.50 (23.40, 40.00) kPa, respectively. Both LSM and SSM values increased with the progression of liver fibrosis, and the difference was statistically significant (P<0.001). LSM and SSM were both positively correlated with liver fibrosis stages (r=0.709 and 0.655, respectively; both P<0.001). The patients were divided into a significant fibrosis group (≥ stage S2) and a non-significant fibrosis group (≤stage S1). The optimal diagnostic cut-off values of LSM and SSM for diagnosing significant liver fibrosis (≥ stage S2) were 7.45 kPa and 20.65 kPa, respectively, with the areas under the receiver operating characteristic curve (AUC) being 0.919 and 0.909. The diagnostic efficacy of LSM for significant liver fibrosis (≥stage S2) was comparable to that of SSM, and the difference was not statistically significant (Z=0.314, P=0.075). The AUC of the combined use of LSM and SSM for diagnosing significant liver fibrosis (≥ stage S2) was 0.948. Compared with the single usage of LSM or SSM, the diagnostic efficacy was significantly improved, and the differences were statistically significant (Z=1.968 and 2.018, P=0.0491 and 0.0436, respectively). Conclusion The diagnostic efficacy of LSM and SSM measured by transient elastography for significant liver fibrosis (≥ stage S2) is comparable, and their combination can improve the diagnostic efficacy.

Key words: Chronic hepatitis B, Transient elastography, Spleen stiffness, Liver stiffness, Liver fibrosis